Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins.
Recent studies have demonstrated that Apo AIV exerts a protective effect against atherosclerosis. Moreover, Qin et al. (Am. J. Physiol. 274 (1998) H1836) have demonstrated that Apo AIV, isolated from rat plasma, exerts an inhibitory effect against Cu(2+)-induced lipid peroxidation of intestinal lymph and LDL. The aim of the study was to investigate whether human Apo AIV exerts a protective effect against Cu(2+)-induced lipid peroxidation. Our results demonstrated that human Apo AIV exerted an inhibitory effect against Cu(2+) and AAPH induced lipid peroxidation of VLDL, as shown by the lower increase in the levels of TBARS and conjugated dienes in lipoproteins preincubated with Apo AIV. In addition, the tryptophan (Trp) and probe 2-(dimethylamino)-6-lauroylnaphthalene (Laurdan) fluorescence studies demonstrated that the modifications of spectral properties in both lipoproteins preincubated with Apo AIV were lower with respect to ox-lipoproteins, suggesting that Apo AIV prevents the modification of physico-chemical properties due to peroxidation.
Ferretti
G
G
Faculty of Medicine, Institute of Biochemistry, University of Ancona, Via Ranieri, 60131, Ancona, Italy.
Bacchetti
T
T
Bicchiega
V
V
Curatola
G
G
D015081:2-Naphthylamine / Q000031:analogs & derivatives*; D000578:Amidines / Q000494:pharmacology; D001054:Apolipoproteins A / Q000494:pharmacology*; D003300:Copper / Q000494:pharmacology; D005453:Fluorescence; D005456:Fluorescent Dyes; D006801:Humans; D007848:Laurates; D015227:Lipid Peroxidation / Q000187:drug effects*; D008079:Lipoproteins, VLDL / Q000378:metabolism*; D016877:Oxidants / Q000494:pharmacology; D014364:Tryptophan / Q000737:chemistry
D000578:Amidines; D001054:Apolipoproteins A; D005456:Fluorescent Dyes; D007848:Laurates; D008079:Lipoproteins, VLDL; D016877:Oxidants; C022205:apolipoprotein A-IV; C046728:2,2'-azobis(2-amidinopropane); D003300:Copper; D014364:Tryptophan; D015081:2-Naphthylamine; C065580:laurdan